Recent Finacing
Recent Raise
ImmuneXcite develops antibody–carbohydrate mAbXcite conjugates that attach beta-1,6-glucan to tumor-targeting monoclonal antibodies to activate complement and neutrophils and recruit T cells against cancer.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors